{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:06:40Z","timestamp":1790068000984,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cgh.2026.01.041","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:13:04Z","timestamp":1770624784000},"page":"2724-2731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-3966","authenticated-orcid":false,"given":"Fasiha","family":"Kanwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camden","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagpreet","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziding","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Page-Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B.","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.01.041_bib1","first-page":"172","article-title":"Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades","volume":"12","author":"Abboud","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2026.01.041_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cgh.2026.01.041_bib4","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.01.041_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102755","article-title":"Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis","volume":"75","author":"Kao","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cgh.2026.01.041_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2020.09.015","article-title":"Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the United States","volume":"20","author":"Kim","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.14309\/ajg.0000000000003494","article-title":"Patient-perceived risk of hepatocellular carcinoma and net benefit of surveillance: a multicenter survey study","volume":"120","author":"Singal","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.01.041_bib8","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1016\/j.cgh.2023.04.019","article-title":"Risk stratification model for hepatocellular cancer in patients with cirrhosis","volume":"21","author":"Kanwal","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jhep.2022.10.035","article-title":"Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"78","author":"Cholankeril","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43608","article-title":"Risk score for hepatocellular cancer in adults without viral hepatitis or cirrhosis","volume":"7","author":"Ilagan-Ying","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cgh.2026.01.041_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2022.03.010","article-title":"An elevated FIB-4 score is associated with an increased incidence of liver cancer: a longitudinal analysis among 248,224 outpatients in Germany","volume":"168","author":"Loosen","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cgh.2026.01.041_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cct.2018.11.008","article-title":"Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: a multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network","volume":"76","author":"Borges","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.cgh.2026.01.041_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.01.041_bib15","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2026.01.041_bib16","series-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2019"},{"key":"10.1016\/j.cgh.2026.01.041_bib17","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cgh.2016.08.026","article-title":"Prediction models for gastrointestinal and liver diseases: too many developed, too few validated","volume":"14","author":"Thrift","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib18","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1053\/j.gastro.2021.01.233","article-title":"International Liver Cancer Association (ILCA) white paper on biomarker development for hepatocellular carcinoma","volume":"160","author":"Singal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.01.041_bib19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.cgh.2024.02.028","article-title":"Validation of the Texas hepatocellular carcinoma risk index predictive model for hepatocellular carcinoma in Asian cohort","volume":"22","author":"Yoo","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.041_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/nep.13913","article-title":"Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)","volume":"26","author":"de Jong","year":"2021","journal-title":"Nephrology (Carlton)"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:41:16Z","timestamp":1790066476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1542356526000704"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}